Cargando…

Towards Facile Radiolabeling and Preparation of Gallium-68-/Bismuth-213-DOTA-[Thi(8), Met(O(2))(11)]-Substance P for Future Clinical Application: First Experiences

Substance P (SP) is a small peptide commonly known as a preferential endogenous ligand for the transmembrane neurokinin-1 receptor. Nuclear Medicine procedures currently involve radiolabeled SP derivatives in peptide radioligand endotherapy of inoperable glioblastoma. Promising clinical results spar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suthiram, Janine, Ebenhan, Thomas, Marjanovic-Painter, Biljana, Sathekge, Mike M., Zeevaart, Jan Rijn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472077/ https://www.ncbi.nlm.nih.gov/pubmed/34575402 http://dx.doi.org/10.3390/pharmaceutics13091326

Ejemplares similares

Development of a Single Vial Kit Solution for Radiolabeling of (68)Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients
por: Ebenhan, Thomas, et al.
Publicado: (2015)

Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi(8),Met(O(2))(11)]-Substance P
por: Suthiram, Janine, et al.
Publicado: (2023)

Preclinical Assessment of a (68)Ga-DOTA-Functionalized Depsipeptide as a Radiodiagnostic Infection Imaging Agent
por: Ebenhan, Thomas, et al.
Publicado: (2017)

Synthesis, (68)Ga-Radiolabeling, and Preliminary In Vivo Assessment of a Depsipeptide-Derived Compound as a Potential PET/CT Infection Imaging Agent
por: Mokaleng, Botshelo B., et al.
Publicado: (2015)

Clinically Applicable Cyclotron-Produced Gallium-68 Gives High-Yield Radiolabeling of DOTA-Based Tracers
por: Jussing, Emma, et al.
Publicado: (2021)

Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling
por: Tsionou, Maria Iris, et al.
Publicado: (2017)

Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET
por: Notni, Johannes, et al.
Publicado: (2012)

(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
por: Sathekge, Mike, et al.
Publicado: (2016)

(68)Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
por: Sathekge, Mike, et al.
Publicado: (2017)

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
por: Morgenstern, Alfred, et al.
Publicado: (2018)

Preclinical Assessment Addressing Intravenous Administration of a [(68)Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
por: Mandiwana, Vusani, et al.
Publicado: (2021)

Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
por: Ebenhan, Thomas, et al.
Publicado: (2014)

Tetraethylammonium tricarbonylchlorido(quinoxaline-2-carboxylato-κ(2) N (1),O)rhenate(I)
por: Suthiram, Janine, et al.
Publicado: (2010)

Fusarinine C, a novel siderophore‐based bifunctional chelator for radiolabeling with Gallium‐68
por: Zhai, Chuangyan, et al.
Publicado: (2015)

Correlation of Somatostatin Receptor-2 Expression with Gallium-68-DOTA-TATE Uptake in Neuroblastoma Xenograft Models
por: Zhang, Libo, et al.
Publicado: (2017)

Validation of Quality Control Parameters of Cassette-Based Gallium-68-DOTA-Tyr3-Octreotate Synthesis
por: Sammartano, Antonino, et al.
Publicado: (2020)

The Impact of (68)Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Tetraethylammonium tricarbonylchlorido(pyrazine-2-carboxylato-N (1),O)rhenate(I)
por: Suthiram, Janine, et al.
Publicado: (2009)

Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE
por: Thisgaard, Helge, et al.
Publicado: (2021)

Synthesis and Radiolabelling of DOTA-Linked Glutamine Analogues with (67,68)Ga as Markers for Increased Glutamine Metabolism in Tumour Cells
por: Pellegrini, Paul A., et al.
Publicado: (2013)

Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method
por: Mueller, Dirk, et al.
Publicado: (2016)

SAT-575 Radiolabeled Somatostatin Receptor Analog (86)Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 in Thyroid Cancer Mice Models
por: Thakur, Shilpa, et al.
Publicado: (2019)

Comparison of 99mTc radiolabeled somatostatin antagonist with [(68) Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor
por: Opalinska, Marta, et al.
Publicado: (2023)

Stability Estimation of Gallium Complexes of DOTA Derivatives for Radiotheranostic Applications
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)

Supply and Clinical Application of Actinium-225 and Bismuth-213
por: Morgenstern, Alfred, et al.
Publicado: (2020)

Development of a Potential Gallium-68-Labelled Radiotracer Based on DOTA-Curcumin for Colon-Rectal Carcinoma: From Synthesis to In Vivo Studies
por: Orteca, Giulia, et al.
Publicado: (2019)

Preliminary Study of New Gallium-68 Radiolabeled Peptide Targeting NRP-1 to Detect Brain Metastases by Positron Emission Tomography
por: Moussaron, Albert, et al.
Publicado: (2021)

Molecular Imaging to the Surgeons Rescue: Gallium-68 DOTA-Exendin-4 Positron Emission Tomography-Computed Tomography in Pre-operative Localization of Insulinomas
por: Pallavi, UN, et al.
Publicado: (2019)

Difficult diagnosis and localization of focal nesidioblastosis: clinical implications of (68)Gallium-DOTA-D-Phe(1)-Tyr(3)-octreotide PET scanning
por: Kim, Jae Ri, et al.
Publicado: (2016)

Metal-Polymer Complexes of Gallium/Gallium-68 with Copolymers of N-Vinylpyrrolidonewith N-Vinylformamideand N-Vinyliminodiacetic Acid: A Hint for Radiolabeling of Water-Soluble Synthetic Flexible Chain Macromolecules
por: Gorshkov, Nikolay I., et al.
Publicado: (2020)

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
por: Ahenkorah, Stephen, et al.
Publicado: (2021)

Dual Radiolabeling as a Technique to Track Nanocarriers: The Case of Gold Nanoparticles
por: Rambanapasi, Clinton, et al.
Publicado: (2015)

Preparation and Biological Study of (68)Ga-DOTA-alendronate
por: Fakhari, Ashraf, et al.
Publicado: (2016)

Synthesis, Radiolabelling and In Vitro Characterization of the Gallium-68-, Yttrium-90- and Lutetium-177-Labelled PSMA Ligand, CHX-A''-DTPA-DUPA-Pep
por: Baur, Benjamin, et al.
Publicado: (2014)

Theragnostic Use of Radiolabelled Dota-Peptides in Meningioma: From Clinical Demand to Future Applications
por: Laudicella, Riccardo, et al.
Publicado: (2019)

Synthesis of DOTA-pyridine chelates for (64)Cu coordination and radiolabeling of αMSH peptide
por: Yang, Hua, et al.
Publicado: (2021)

Fully automated radiolabeling of [(68)Ga]Ga-EMP100 targeting c-MET for PET-CT clinical imaging
por: Rusu, Timofei, et al.
Publicado: (2023)

Gallium-68 DOTA-TATE Positron Emission Tomography/Computed Tomography: Scintigraphic Changes of Adrenal Glands Following Management of Ectopic Cushing's Syndrome by Steroidogenesis Inhibitors
por: Huang, Yu-Ting, et al.
Publicado: (2014)

A toxicity profile of the Pheroid® technology in rodents
por: Kleynhans, Janke, et al.
Publicado: (2019)

(68)Ga, (44)Sc and (177)Lu-labeled AAZTA(5)-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues
por: Sinnes, Jean-Philippe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_90scs14or8s4kjj8bi2a0ercg7